Table 1.
Clinical characteristics and 11C-choline positron emission tomography and computed tomography (PET/CT) metabolic parameters of patients.
| PCa (n=74) | Benign prostate disease (n=43) | P value | |
|---|---|---|---|
| Age, median (IQR) | 73(63-81) | 71(64-79) | 0.160 |
| BMI, mean ± SD | 23.82 ± 2.99 | 24.19 ± 3.29 | 0.600 |
| History of diabetes, n (%) | 18(24) | 11(26) | 0.891 |
| History of hypertension, n (%) | 26(35) | 16(37) | 0.915 |
| GS PSA, (ng/ml) MTV, mean ± SD |
7.51 ± 0.81 14.82 ± 5.87 9.80 ± 11.15 |
NA 7.85 ± 3.44 9.78 ± 5.40 |
NA 0.005 0.995 |
| TLG, mean ± SD | 24.86 ± 10.36 | 17.21 ± 9.99 | 0.174 |
| SUVmax, mean ± SD | 3.80 ± 0.67 | 2.70 ± 0.72 | 0.016 |
| SUVmean, mean ± SD | 3.14 ± 0.74 | 1.86 ± 0.87 | 0.010 |
| P/M ratio, mean ± SD | 4.59 ± 0.82 | 3.17 ± 0.76 | 0.008 |
BMI, Body Mass Index; GS, Gleason Score; NA, Not Acquired; PSA, Prostate-Specific Antigen.
The bold values provided means the significant meaning in statistics because their P values are less than 0.05.